Literature DB >> 10678870

Expressing the magnitude of adverse effects in case-control studies: "the number of patients needed to be treated for one additional patient to be harmed".

L M Bjerre1, J LeLorier.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10678870      PMCID： PMC1127536          DOI： 10.1136/bmj.320.7233.503

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.

Authors:  L Abenhaim; Y Moride; F Brenot; S Rich; J Benichou; X Kurz; T Higenbottam; C Oakley; E Wouters; M Aubier; G Simonneau; B Bégaud
Journal:  N Engl J Med       Date:  1996-08-29       Impact factor: 91.245

Review 2.  Confidence intervals for the number needed to treat.

Authors:  D G Altman
Journal:  BMJ       Date:  1998-11-07

3.  An assessment of clinically useful measures of the consequences of treatment.

Authors:  A Laupacis; D L Sackett; R S Roberts
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

4.  The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding.

Authors:  J L Carson; B L Strom; K A Soper; S L West; M L Morse
Journal:  Arch Intern Med       Date:  1987-01

5.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

6.  Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.

Authors:  H Jick; S S Jick; V Gurewich; M W Myers; C Vasilakis
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

7.  Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Authors: 
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

8.  Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.

Authors:  W O Spitzer; M A Lewis; L A Heinemann; M Thorogood; K D MacRae
Journal:  BMJ       Date:  1996-01-13
  8 in total
  17 in total

1.  A population perspective to evidence based medicine: "evidence for population health".

Authors:  R F Heller; J Page
Journal:  J Epidemiol Community Health       Date:  2002-01       Impact factor: 3.710

Review 2.  Impact numbers: measures of risk factor impact on the whole population from case-control and cohort studies.

Authors:  R F Heller; A J Dobson; J Attia; J Page
Journal:  J Epidemiol Community Health       Date:  2002-08       Impact factor: 3.710

3.  Impact numbers in health policy decisions.

Authors:  J Attia; J Page; R F Heller; A J Dobson
Journal:  J Epidemiol Community Health       Date:  2002-08       Impact factor: 3.710

4.  Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study.

Authors:  Giovanni Corrao; Antonella Zambon; Lorenza Bertù; Anna Mauri; Valentina Paleari; Camillo Rossi; Mauro Venegoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 5.  New knowledge, new insights, and new recommendations.

Authors:  P Fleming; P Blair; J McKenna
Journal:  Arch Dis Child       Date:  2006-10       Impact factor: 3.791

6.  Healthy start program and feto-infant morbidity outcomes: evaluation of program effectiveness.

Authors:  Hamisu M Salihu; Alfred K Mbah; Delores Jeffers; Amina P Alio; Lo Berry
Journal:  Matern Child Health J       Date:  2008-08-09

7.  Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomized clinical trials and observational studies.

Authors:  Vera E Valkhoff; Miriam C J M Sturkenboom; Catherine Hill; Sander Veldhuyzen van Zanten; Ernst J Kuipers
Journal:  Can J Gastroenterol       Date:  2013-03       Impact factor: 3.522

8.  Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study.

Authors:  Jesper Hallas; Michael Dall; Alin Andries; Birthe Søgaard Andersen; Claus Aalykke; Jane Møller Hansen; Morten Andersen; Annmarie Touborg Lassen
Journal:  BMJ       Date:  2006-09-19

9.  Concurrent use of tramadol and oral vitamin K antagonists and the risk of excessive anticoagulation: a register-based nested case-control study.

Authors:  Anton Pottegård; Peter M Meegaard; Line H V Holck; Rene dePont Christensen; Hanne Madsen; Jesper Hallas
Journal:  Eur J Clin Pharmacol       Date:  2012-07-31       Impact factor: 2.953

Review 10.  Stroke in chronic kidney disease: prevention and management.

Authors:  Raymond R Townsend
Journal:  Clin J Am Soc Nephrol       Date:  2008-01       Impact factor: 8.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.